Cardiovascular Systems price target raised to $21 from $15 at JMP Securities

January 31, 2013

JMP Securities raised its target on Cardiovascular Systems after the company reported higher than expected Q2 revenue. The firm believes that the stock is undervalued and it reiterates an Outperform rating.